CEL-SCI Corporation vs Gradalis, Inc.

CEL-SCI Corporation logo

CEL-SCI Corporation

Dedicated to research and development directed at improving the treatment of cancer, autoimmune and infectious diseases

45 employees · est. 1983 · Vienna, United States

VS
Gradalis, Inc. logo

Gradalis, Inc.

Leading a new way to fight cancer

24 employees · est. 2003 · Carrollton, United States

CEL-SCI Corporation is the older company (1983 vs 2003).

Side-by-Side Comparison

CEL-SCI Corporation Gradalis, Inc.
Founded
1983 older 2003
Headquarters
Vienna, United States Carrollton, United States
Employees
45 24
Industry
Biotechnology, Health Care Biotechnology, Health Care, Manufacturing
Funding Stage
Post-IPO Equity Grant
Total Funding
$86.03M Not tracked yet
Funding Rounds
11 Not tracked yet
Website
cel-sci.com gradalisinc.com
CEL-SCI Corporation logo

About CEL-SCI Corporation

Cel-Sci is a biotechnology company dedicated to researching and developing treatments for cancer, autoimmune, and infectious diseases. The company's flagship product, Multikine, aims to boost the patient's immune system to target tumors while it is still intact and before conventional therapies. In...

Gradalis, Inc. logo

About Gradalis, Inc.

Gradalis is a late-stage clinical biotechnology company developing immunotherapies for multiple cancer indications including an upcoming Phase 3 registration trial in patients with ovarian cancer. The company’s proprietary bi-shRNA therapy platform, which has been proven in its clinical studies, can...

Also comparing in this category

Comparing more than these two?

Get CEL-SCI Corporation, Gradalis, Inc. and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does CEL-SCI Corporation compare?

A PDF of CEL-SCI Corporation and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Frequently Asked Questions

CEL-SCI Corporation was founded in 1983, based in Vienna, United States, with 45 employees. Cel-Sci is a biotechnology company dedicated to researching and developing treatments for cancer, autoimmune, and infectious diseases. The company's flagship product, Multikine, aims to boost the pati. Gradalis, Inc. was founded in 2003, based in Carrollton, United States, with 24 employees. Gradalis is a late-stage clinical biotechnology company developing immunotherapies for multiple cancer indications including an upcoming Phase 3 registration trial in patients with ovarian cancer. The.
CEL-SCI Corporation has raised $86.03M and Gradalis, Inc. no disclosed funding. Latest stage: CEL-SCI Corporation Post-IPO Equity, Gradalis, Inc. Grant.
Both work in Biotechnology and Health Care.

Compare CEL-SCI Corporation with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at CEL-SCI Corporation on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes